From Code
Rebecca Docherty works from home near Edinburgh, writing code for AI models that help researchers find new medicines and analyse brain scans. Her work involves sifting through millions of molecules to identify potential treatments. This is a growing field, driven by increasing demand for expertise in computer science and AI.
Breaking news
OpenAI Settles Discrimination Claim for $3.2 Million
Pharma Executive Eyed for NIAID Director Role
Annie Jacobsen and Geoff Bennett Discuss Biological Threats
Arts Program Targets Loneliness in North CarolinaThe University of Bath's online MSc programme played a significant role in Docherty's career change. She was drawn to the programme's flexibility and the opportunity to specialise in AI and machine learning. The course equipped her with the skills needed to build complex AI models.
Can AI Accelerate Medical Breakthroughs?
Docherty's AI models are used to support preclinical research, helping scientists to identify promising compounds and understand how they work. One of the key challenges in drug discovery is the vast number of molecules that need to be analysed. AI can help to speed up this process, reducing the time and cost associated with bringing new treatments to market.
Frequently Asked Questions
As the demand for AI expertise in the life sciences continues to grow, the University of Bath's online programme is helping to meet this need. By providing students with the skills and knowledge required to build and apply AI models, the course is enabling a new generation of researchers to drive innovation in the field.
The increasing use of AI in drug discovery is likely to have a significant impact on the development of new treatments. As the technology continues to evolve, we can expect to see more efficient and effective approaches to identifying potential medicines.
